Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor
NCT07549022
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Malignant Peripheral Nerve Sheath Tumors
MPNST
Interventions
DRUG:
BMS-986504
Sponsor
Ankit Mangla, MD